Dr Greg Roger has been appointed to the Prostheses List Advisory Committee (PLAC) by the Minister of Health, the Hon Sussan Ley. As part of the government’s agenda to reform the cost of medical devices, the committee has been tasked with advising the government on additional changes to the prosthesis list. As a former board […]
The time is now for Australia to take definitive steps to promote a thriving Medical Device sector which employs people, creates wealth and improves Australia’s future in a competitive world. CSL’s decision to locate a new plant in Switzerland speaks to the need for the AIM Tax Incentive, which has been clearly shown.
Removing bureaucratic hurdles, through the JOBS Act in the US, has been shown to directly stimulate commercialisation of innovation.
At a private reception at his home, H.E. Kim Beazley met with Dr Roger, who was able to discuss with the Ambassador and his advisors the import of his recent visit to the Walter Reed Hospital and the role of statistical methods and data mining in improving health care outcomes and reducing costly wastage of resources.
Following his meetings at BIO Dr Roger was able to meet with the CEO of CONNECT, Greg McKee, to explore collaborations between this US-wide, Californian based innovation network and Australian firms wishing to export to the USA.
On a recent trip to New Zealand, Dr Roger met with David Budgett, Associate Professor, Technology Development Leader Auckland Bioengineering Institute (ABI) at the University of Auckland. Dr Roger was able to review the ABIs world-class research in tissue modeling and inducted power sources for medical devices.